Recent Company News

• 01:32 AM ET Nov 26, 2025
  

  Sanofi headquarters searched as part of an investigation involving Société Générale on suspicions of tax fraud -- Le Monde (25-Nov post EU close) (€86.39, 0.00)

• 01:02 AM ET Nov 25, 2025
  

  EC approves Regeneron's Dupixent to treat moderate-to-severe CSU ($761.45, 0.00)

• 08:09 AM ET Nov 24, 2025
  

  DarioHealth announces publication of Sanofi study in JMIR demonstrating An estimated $5,077 medical cost savings per Dario Digital Health platform user per year ($13.91, 0.00)

• 03:58 PM ET Nov 20, 2025
  

  Texas Attorney General sues Bris­tol-Myers Squibb and Sanofi alleging failure to disclose Plavix ineffectiveness in certain patients

• 07:04 AM ET Nov 19, 2025
  

  Regeneron Pharmaceuticals announces EC approves Libtayo as adjuvant treatment for adult patients with CSCC at high risk of recurrence after surgery and radiation ($725.34, 0.00)

• 09:36 AM ET Nov 17, 2025
  

  StreetAccount Summary - Private company transactions for the week ended 15-Nov

• 08:54 AM ET Nov 14, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:37 AM ET Nov 14, 2025
  

  EMA CHMP publishes summary of opinions for November 2025 meeting

• 06:39 AM ET Nov 14, 2025
  

  EU's CHMP adopted a positive opinion recommending the granting of a marketing authorisation for Teizeild (€89.43, -1.01)

• 08:54 AM ET Nov 12, 2025
  

  CDC ACIP to meet next on Dec 4-5, 2025